BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering
Bryan, Garnier & Co acts as Sole Financial Advisor to Calliditas Therapeutics on its acquisition of Genkyotex for €88 million
Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering
Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud
Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors
Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering
Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 37 million upsized Follow-on Offering
1
…
5
6
7
8
9
…
18
Privacy Preference Center
Privacy Preferences